Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$971M |
| 3 |
Tesla
TSLA
|
+$937M |
| 4 |
NVIDIA
NVDA
|
+$773M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$742M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$291M |
| 2 |
Willis Towers Watson
WTW
|
+$256M |
| 3 |
KSU
Kansas City Southern
KSU
|
+$227M |
| 4 |
Salesforce
CRM
|
+$225M |
| 5 |
Advanced Micro Devices
AMD
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.9% |
| 2 | Financials | 6.62% |
| 3 | Healthcare | 6.1% |
| 4 | Consumer Discretionary | 4.86% |
| 5 | Industrials | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $6.21M | ﹤0.01% |
527,803
+300,288
| +132% | +$3.69M |
|
2627
Ingevity
NGVT
$2.51B
| $6.2M | ﹤0.01% |
86,502
-185,846
| -68% | -$14.1M |
|
|
NOTV
2628
DELISTED
Inotiv
NOTV
| $6.2M | ﹤0.01% |
147,411
+90,377
| +158% | +$4.04M |
|
|
PMVC
2629
DELISTED
PMV Consumer Acquisition Corp.
PMVC
| $6.2M | ﹤0.01% |
630,576
-2,242
| -0.4% | -$22K |
|
|
CMCAU
2630
DELISTED
Capitalworks Emerging Markets Acquisition Corp Unit
CMCAU
| $6.19M | ﹤0.01% |
+615,000
| New | +$6.19M |
|
2631
Alpha Teknova
TKNO
$268M
| $6.19M | ﹤0.01% |
302,107
+45,763
| +18% | +$1.01M |
|
|
KAIRU
2632
DELISTED
Kairos Acquisition Corp. Unit
KAIRU
| $6.18M | ﹤0.01% |
618,159
-39,841
| -6% | -$399K |
|
2633
Martin Marietta Materials
MLM
$31.5B
| $6.18M | ﹤0.01% |
14,030
-14,948
| -52% | -$6.06M |
|
|
FIRY
2634
Firy Inc
FIRY
$148M
| $6.18M | ﹤0.01% |
41,509
-44,237
| -52% | -$8.5M |
|
|
TWNI
2635
DELISTED
Tailwind International Acquisition Corp.
TWNI
| $6.17M | ﹤0.01% |
632,824
-11,241
| -2% | -$110K |
|
|
ADAP
2636
DELISTED
Adaptimmune Therapeutics
ADAP
| $6.16M | ﹤0.01% |
1,643,478
+58,629
| +4% | +$267K |
|
|
SHAC
2637
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $6.16M | ﹤0.01% |
628,766
+92,428
| +17% | +$902K |
|
|
GTPA
2638
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
| $6.15M | ﹤0.01% |
625,836
-51,194
| -8% | -$505K |
|
2639
PUT
KKR & Co
KKR
$91.1B
| $6.15M | ﹤0.01% |
+82,500
| New | +$6.09M |
|
2640
Phibro Animal Health
PAHC
$1.47B
| $6.14M | ﹤0.01% |
300,549
-34,405
| -10% | -$735K |
|
|
EPHY
2641
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
| $6.13M | ﹤0.01% |
628,399
-56,060
| -8% | -$548K |
|
2642
GoodRx Holdings
GDRX
$1.04B
| $6.13M | ﹤0.01% |
+187,569
| New | +$7.55M |
|
2643
Granite Construction
GVA
$5.29B
| $6.13M | ﹤0.01% |
158,289
+126,387
| +396% | +$5.01M |
|
|
YALA
2644
Yalla Group
YALA
$818M
| $6.12M | ﹤0.01% |
912,642
+888,695
| +3,711% | +$6.3M |
|
|
CIO
2645
DELISTED
City Office REIT
CIO
| $6.12M | ﹤0.01% |
310,211
+103,656
| +50% | +$1.9M |
|
2646
NMI Holdings
NMIH
$3.33B
| $6.12M | ﹤0.01% |
279,882
+134,811
| +93% | +$2.99M |
|
|
PSTX
2647
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $6.11M | ﹤0.01% |
896,514
-13,342
| -1% | -$90.9K |
|
2648
PRA Group
PRAA
$663M
| $6.1M | ﹤0.01% |
121,555
+98,678
| +431% | +$4.39M |
|
|
MSPR
2649
DELISTED
MSP Recovery Inc
MSPR
| $6.1M | ﹤0.01% |
140
+25
| +22% | +$1.09M |
|
2650
Sable Offshore Corp
SOC
$1.01B
| $6.09M | ﹤0.01% |
626,708
+395,463
| +171% | +$3.85M |
|
Similar funds
Millennium Management's Q4 2021 Portfolio in Review
As of Q4 2021, Millennium Management held 7,926 positions worth $197B, up 18% from $167B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Millennium Management deployed $20.8B of net new capital in Q4 2021, opening 1,213 new positions and adding to 2,561 existing holdings. Its largest new stake was Comcast: 3,028,627 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $291M trimmed.
- Millennium Management's largest Q4 2021 buy was Comcast: 3,028,627 shares worth $152M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $1.38B increase.
- Millennium Management's biggest Q4 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $291M.
- Millennium Management fully exited Kansas City Southern in Q4 2021, selling an estimated $227M.
- Millennium Management's ten largest holdings make up 19% of its $197B portfolio in Q4 2021.
- Millennium Management opened 1,213 new positions and closed 1,232 in Q4 2021.
- Millennium Management's portfolio value rose 18% quarter-over-quarter to $197B.
Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.